Mohamed Gomaa Kamel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mohamed Gomaa Kamel has a total of 210 co-authors. Here are the top co-authors by number of shared publications:
- Nguyen Tien Huy
Institute of Research and Development Duy Tan University Da Nang Vietnam
20 shared publications - Kenji Hirayama
School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
8 shared publications - Nguyen Lam Vuong
Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
5 shared publications Kenji Hirayama
4 shared publications- Mostafa Ebraheem Morra
Faculty of Medicine, Al-Azhar University, Cairo, Egypt
4 shared publications - Sherief Ghozy
Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
4 shared publications
Latest Publications
- 21 July 2026
- Published by BMJ in Emergency Medicine Journal
- Vol. 43 (8) , 526-527
Journal update monthly top five
- 21 July 2026
- Published by BMJ in Emergency Medicine Journal
- Vol. 43 (8) , 526-527
Journal update monthly top five
- 30 March 2026
- Published by BMJ in Emergency Medicine Journal
- Vol. 43 (4) , 260-261
Journal update monthly top five
- 30 March 2026
- Published by BMJ in Emergency Medicine Journal
- Vol. 43 (4) , 260-261
Journal update monthly top five
- Open Access
- 8 August 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-9
New biomarkers for liver involvement by dengue infection in adult Vietnamese patients: a case-control study
Liver injury with marked elevation of aspartate aminotransferase enzyme (AST) is commonly observed in dengue infection. To understand the pathogenesis of this liver damage, we compared the plasma levels of hepatic specific, centrilobular predominant enzymes (glutamate dehydrogenase, GLDH; glutathione S transferase-α, αGST), periportal enriched 4-hydroxyphenylpyruvate dioxygenase (HPPD), periportal predominant arginase-1 (ARG-1), and other non-specific biomarkers (paraoxonase-1, PON-1) in patients with different outcomes of dengue infection. This hospital-based study enrolled 87 adult dengue patients, stratified into three groups based on plasma AST levels (< 80, 80–400, > 400 U/L) in a 1:1:1 ratio (n = 40, n = 40, n = 40, respectively. The new liver enzymes in the blood samples from the 4th to 6th days of their illness were measured by commercial enzyme-linked immunosorbent assay (ELISA) or colorimetric kits. Based on the diagnosis at discharge days, our patients were classified as 40 (46%) dengue without warning signs (D), 35 (40.2%) dengue with warning signs (DWS), and 11 (12.6%) severe dengue (SD) with either shock (two patients) or AST level over 1000 U/L (nine patients), using the 2009 WHO classification. The group of high AST (> 400 U/L) also had higher ALT, GLDH, ARG-1, and HPPD than the other groups, while the high (> 400 U/L) and moderate (80–400 U/L) AST groups had higher ALT, αGST, ARG-1, and HPPD than the low AST group (< 80 U/L). There was a good correlation between AST, alanine aminotransferase enzyme (ALT), and the new liver biomarkers such as GLDH, αGST, ARG-1, and HPPD. Our findings suggest that dengue-induced liver damage initiates predominantly in the centrilobular area toward the portal area during the dengue progression. Moreover, these new biomarkers should be investigated further to explain the pathogenesis of dengue and to validate their prognostic utility. Arginase-1, α-glutathione S transferase, and 4-hydroxyphenylpyruvate dioxygenase levels were significantly associated with dengue severity and can serve as good prognostic predictors for liver injury. Our findings suggest that dengue-induced liver damage initiates predominantly in the centrilobular area toward the portal area during the dengue progression.
- 8 August 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-9
Open AccessNew biomarkers for liver involvement by dengue infection in adult Vietnamese patients: a case-control study
Liver injury with marked elevation of aspartate aminotransferase enzyme (AST) is commonly observed in dengue infection. To understand the pathogenesis of this liver damage, we compared the plasma levels of hepatic specific, centrilobular predominant enzymes (glutamate dehydrogenase, GLDH; glutathione S transferase-α, αGST), periportal enriched 4-hydroxyphenylpyruvate dioxygenase (HPPD), periportal predominant arginase-1 (ARG-1), and other non-specific biomarkers (paraoxonase-1, PON-1) in patients with different outcomes of dengue infection. This hospital-based study enrolled 87 adult dengue patients, stratified into three groups based on plasma AST levels (< 80, 80–400, > 400 U/L) in a 1:1:1 ratio (n = 40, n = 40, n = 40, respectively. The new liver enzymes in the blood samples from the 4th to 6th days of their illness were measured by commercial enzyme-linked immunosorbent assay (ELISA) or colorimetric kits. Based on the diagnosis at discharge days, our patients were classified as 40 (46%) dengue without warning signs (D), 35 (40.2%) dengue with warning signs (DWS), and 11 (12.6%) severe dengue (SD) with either shock (two patients) or AST level over 1000 U/L (nine patients), using the 2009 WHO classification. The group of high AST (> 400 U/L) also had higher ALT, GLDH, ARG-1, and HPPD than the other groups, while the high (> 400 U/L) and moderate (80–400 U/L) AST groups had higher ALT, αGST, ARG-1, and HPPD than the low AST group (< 80 U/L). There was a good correlation between AST, alanine aminotransferase enzyme (ALT), and the new liver biomarkers such as GLDH, αGST, ARG-1, and HPPD. Our findings suggest that dengue-induced liver damage initiates predominantly in the centrilobular area toward the portal area during the dengue progression. Moreover, these new biomarkers should be investigated further to explain the pathogenesis of dengue and to validate their prognostic utility. Arginase-1, α-glutathione S transferase, and 4-hydroxyphenylpyruvate dioxygenase levels were significantly associated with dengue severity and can serve as good prognostic predictors for liver injury. Our findings suggest that dengue-induced liver damage initiates predominantly in the centrilobular area toward the portal area during the dengue progression.
- Open Access
- 1 September 2021
- Published by Elsevier in Translational Oncology
- Vol. 14 (9) , 101156
Comment on: A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma
- 1 September 2021
- Published by Elsevier in Translational Oncology
- Vol. 14 (9) , 101156
Open AccessComment on: A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma
- 25 April 2021
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 21 (5) , 505-514
The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis
The world urgently requires surrogate markers to diagnose COVID-19 and predict its progression. The severity is not easily predicted via currently used biomarkers. Critical COVID‐19 patients need t...
- 25 April 2021
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 21 (5) , 505-514
The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis
The world urgently requires surrogate markers to diagnose COVID-19 and predict its progression. The severity is not easily predicted via currently used biomarkers. Critical COVID‐19 patients need t...
- Open Access
- 24 February 2021
- Published by Taylor & Francis in Future Virology
- Vol. 16 (3) , 191-199
Epidemiologic Features and Clinical Course of COVID-19: A Retrospective Analysis of 19 Patients in Germany
Background: SARS-coronavirus-2 causes coronavirus disease-19 (COVID-19). Materials & methods: We here report epidemiology; clinical, radiological and laboratory characteristics; and outcomes of COV...
- 24 February 2021
- Published by Taylor & Francis in Future Virology
- Vol. 16 (3) , 191-199
Open AccessEpidemiologic Features and Clinical Course of COVID-19: A Retrospective Analysis of 19 Patients in Germany
Background: SARS-coronavirus-2 causes coronavirus disease-19 (COVID-19). Materials & methods: We here report epidemiology; clinical, radiological and laboratory characteristics; and outcomes of COV...
- 1 August 2020
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 9 (12) , 877-889
Using the primary site as a prognostic tool for nodal mantle cell lymphoma: a SEER-based study
Background:Nodal mantle cell lymphoma (NMCL) has a worse survival than extra-nodal mantle cell lymphoma.Materials & methods:A cohort study was conducted to evaluate the primary site role as a mortality predictor using data from 1983 to 2011 from the Surveillance, Epidemiology, and End Results (SEER) database.Results:Most patients had NMCL in multiple regions (71.9%). There was a significantly increased incidence of NMCL cases over years with 83.2% of them occurred between 1998 and 2011. The mean survival was 52.9 months with overall survival/cancer-specific survival rate of 29.2/42.9%, respectively. Lymph nodes of intrathoracic and multiple regions had a worse overall survival while the head, face and neck, intra-abdominal, pelvic, inguinal region and leg as well as multiple regions had worse cancer-specific survival.Conclusion:NMCL primary site can serve as a prognostic factor. We encourage adding it to MCL International Prognostic Index.
- 1 August 2020
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 9 (12) , 877-889
Using the primary site as a prognostic tool for nodal mantle cell lymphoma: a SEER-based study
Background:Nodal mantle cell lymphoma (NMCL) has a worse survival than extra-nodal mantle cell lymphoma.Materials & methods:A cohort study was conducted to evaluate the primary site role as a mortality predictor using data from 1983 to 2011 from the Surveillance, Epidemiology, and End Results (SEER) database.Results:Most patients had NMCL in multiple regions (71.9%). There was a significantly increased incidence of NMCL cases over years with 83.2% of them occurred between 1998 and 2011. The mean survival was 52.9 months with overall survival/cancer-specific survival rate of 29.2/42.9%, respectively. Lymph nodes of intrathoracic and multiple regions had a worse overall survival while the head, face and neck, intra-abdominal, pelvic, inguinal region and leg as well as multiple regions had worse cancer-specific survival.Conclusion:NMCL primary site can serve as a prognostic factor. We encourage adding it to MCL International Prognostic Index.
- 30 June 2020
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 18 (10) , 1005-1020
Possible therapeutic agents for COVID-19: a comprehensive review
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein, we represented possible therapeutic agents that may stand as a potential therapy against COVID-19. We searched PubMed, Google Scholar, and clinicaltrials.gov for relevant papers. We showed some agents with potentially favorable efficacy, acceptable safety as well as good pharmacokinetic profiles. Several therapies are under assessment to evaluate their efficacy and safety for COVID-19. However, some drugs were withdrawn due to their side effects after demonstrating some clinical efficacy. Indeed, the most effective therapies could be organ function support, convalescent plasma, anticoagulants, and immune as well as antiviral therapies, especially anti-influenza drugs due to the similarities between respiratory viruses regarding viral entry, uncoating, and replication. We encourage giving more attention to favipiravir, remdesivir, and measles vaccine. A combination, at least dual or even triple therapy, of the aforementioned efficacious and safe therapies is greatly recommended for COVID-19. Further, patients should have a routine assessment for their coagulation and bleeding profiles as well as their inflammatory and cytokine concentrations.
- 30 June 2020
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 18 (10) , 1005-1020
Possible therapeutic agents for COVID-19: a comprehensive review
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein, we represented possible therapeutic agents that may stand as a potential therapy against COVID-19. We searched PubMed, Google Scholar, and clinicaltrials.gov for relevant papers. We showed some agents with potentially favorable efficacy, acceptable safety as well as good pharmacokinetic profiles. Several therapies are under assessment to evaluate their efficacy and safety for COVID-19. However, some drugs were withdrawn due to their side effects after demonstrating some clinical efficacy. Indeed, the most effective therapies could be organ function support, convalescent plasma, anticoagulants, and immune as well as antiviral therapies, especially anti-influenza drugs due to the similarities between respiratory viruses regarding viral entry, uncoating, and replication. We encourage giving more attention to favipiravir, remdesivir, and measles vaccine. A combination, at least dual or even triple therapy, of the aforementioned efficacious and safe therapies is greatly recommended for COVID-19. Further, patients should have a routine assessment for their coagulation and bleeding profiles as well as their inflammatory and cytokine concentrations.
- 24 June 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (10) , 2238-2242
First case of focal epilepsy associated with SARS‐coronavirus‐2
A healthy patient presented to Klinikum Altmühlfranken Weißenburg Hospital, Germany, with two morning attacks of painful muscle spasm in the left upper and lower limbs, without altered consciousness. Full examinations, radiological imaging, electroencephalography, lumbar puncture, and autoimmune profile were either normal or not consistent with patient's complaint. Subsequent epileptic episodes were observed on admission day and the following days; thus, the patient was diagnosed with focal epilepsy. The patient started to develop a fever and severe cough on day 4, and SARS‐coronavirus‐2 was confirmed through a nasopharyngeal swap. She received anticonvulsants and symptomatic treatments and completely recovered. This report emphasizes the potential nervous system involvement in severe acute respiratory syndrome‐coronavirus‐2 pathogenesis.
- 24 June 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (10) , 2238-2242
First case of focal epilepsy associated with SARS‐coronavirus‐2
A healthy patient presented to Klinikum Altmühlfranken Weißenburg Hospital, Germany, with two morning attacks of painful muscle spasm in the left upper and lower limbs, without altered consciousness. Full examinations, radiological imaging, electroencephalography, lumbar puncture, and autoimmune profile were either normal or not consistent with patient's complaint. Subsequent epileptic episodes were observed on admission day and the following days; thus, the patient was diagnosed with focal epilepsy. The patient started to develop a fever and severe cough on day 4, and SARS‐coronavirus‐2 was confirmed through a nasopharyngeal swap. She received anticonvulsants and symptomatic treatments and completely recovered. This report emphasizes the potential nervous system involvement in severe acute respiratory syndrome‐coronavirus‐2 pathogenesis.
- Open Access
- 15 June 2020
- Published by Wiley
Epidemiologic Features and Clinical Course of COVID-19: a Retrospective Analysis of 19 Patients in Germany
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease-19 (CoVID-19). The virus has exhibited unprecedented human to human transmission and progressed into a pandemic over a short duration. Aim To report the epidemiology; clinical, radiological, and laboratory characteristics; and outcome of SARS-CoV-2 infection in 19 patients in Germany. Methods Retrospective analysis of 19 patients contracting SARS-CoV-2 infection confirmed by PCR in Germany between March 1, 2020 and March 31, 2020. Results In 19 PCR-confirmed SARS-Cov-2 virus infection (median age 69 years; 12 (63%) males), the most common presentations were Fever (79%), cough (79%), fatigue (79%), and dyspnea (42%). The most common comorbidities were hypertension (47%), hypothyroidism (32%), and cardiac diseases (32%). According to chest X-ray, 15 (79%) of patients had abnormal chest X-rays; of these, 13 had bilateral chest infiltrates and two had unilateral infiltrates. Lactate dehydrogenase and C-reactive protein (CRP) were elevated in all patients at baseline investigations; 343 U/L (169-931 U/L) and 8 mg/dL (1-17 mg/dL), respectively. Of the 19 cases, 13 (68.4%) recovered and discharged, 9 (47.3%) needed ICU admission, and 4 (21.1%) cases died. Conclusion Among the 19 patients diagnosed with SARS-CoV-2, mild respiratory tract infections symptoms were frequently reported. Some patients required supplemental oxygen and had variable clinical outcomes following supportive and antibiotic treatments. These findings may contribute to the development of more effective strategies of infection control.
- 15 June 2020
- Published by Wiley
Open AccessEpidemiologic Features and Clinical Course of COVID-19: a Retrospective Analysis of 19 Patients in Germany
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease-19 (CoVID-19). The virus has exhibited unprecedented human to human transmission and progressed into a pandemic over a short duration. Aim To report the epidemiology; clinical, radiological, and laboratory characteristics; and outcome of SARS-CoV-2 infection in 19 patients in Germany. Methods Retrospective analysis of 19 patients contracting SARS-CoV-2 infection confirmed by PCR in Germany between March 1, 2020 and March 31, 2020. Results In 19 PCR-confirmed SARS-Cov-2 virus infection (median age 69 years; 12 (63%) males), the most common presentations were Fever (79%), cough (79%), fatigue (79%), and dyspnea (42%). The most common comorbidities were hypertension (47%), hypothyroidism (32%), and cardiac diseases (32%). According to chest X-ray, 15 (79%) of patients had abnormal chest X-rays; of these, 13 had bilateral chest infiltrates and two had unilateral infiltrates. Lactate dehydrogenase and C-reactive protein (CRP) were elevated in all patients at baseline investigations; 343 U/L (169-931 U/L) and 8 mg/dL (1-17 mg/dL), respectively. Of the 19 cases, 13 (68.4%) recovered and discharged, 9 (47.3%) needed ICU admission, and 4 (21.1%) cases died. Conclusion Among the 19 patients diagnosed with SARS-CoV-2, mild respiratory tract infections symptoms were frequently reported. Some patients required supplemental oxygen and had variable clinical outcomes following supportive and antibiotic treatments. These findings may contribute to the development of more effective strategies of infection control.